K

Active Director Director DIN 08962530
DIN 08962530 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Kaliswari

Data last updated:

Kaliswari is a Director at Genezenindus Hospital Private Limited (since 2020). The company operates in Healthcare. Genezenindus Hospital Private Limited reported revenue of ₹3.47 Cr (FY 2025).

DIN 08962530
Primary Designation Director
Industry Healthcare
First Appointment 20 Nov 2020
Oldest Company Age 5 yrs
Largest company Genezenindus Hospital Private Limited · ₹3.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20202020₹3.47 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Genezenindus Hospital Private Limited
Premium access

Shareholding and investment profile for Kaliswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaliswari

Kaliswari currently holds 1 directorship: Genezenindus Hospital Private Limited (Director, since 20 Nov 2020, revenue ₹3.47 Cr (FY 2025)).

Kaliswari was first appointed on 20 Nov 2020 as Director at Genezenindus Hospital Private Limited.

The current boards of Kaliswari's companies include Aisswarya Lakshmi (Genezenindus Hospital Private Limited), Alexander Roy Jenifer Anjana (Genezenindus Hospital Private Limited), Anandapadmanaban Ambiha (Genezenindus Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available